Both non-small-cell lung carcinoma (NSCLC) and small-cell lung carcinoma (SCLC) patients have been reported to show high CHI3L1 expression and serum levels, and these have been reported to be associated with poorer overall survival. Here, CHI3L1 is linked to non-small cell lung carcinoma.